Clinical efficacy of Atosiban in different doses for patients during embryo transfer

A Randomized controlled trial to evaluate the efficacy of Atosiban in patients undergoing Embryo transfer. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076392

Enrollment

Registered

2024-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N972- Female infertility of uterine origin

Interventions

Intervention1: Giving Atosibanto patients undergoing embryo transfer: Patients undergoing embryo transfer who fulfil our inclusion criteria are divided into two groups, the first group getting Atosiba

Eligibility

Inclusion criteria

Inclusion criteria: Previous atleast one implantation failure Adenomyosis - by MUSA classification Grade A and B embryos

Exclusion criteria

Exclusion criteria: Hydrosalpinges on scan and untreated Moderate or severe endometriosis Abnormal Chromosome in either or both partners Fibroids - FIGO 0,1,2 Uncorrected septate uterus

Design outcomes

Primary

Measure	Time frame
Biochemical Pregnancy rateTimepoint: 5 weeks	—

Secondary

Measure	Time frame
Implantation RateTimepoint: 6 weeks of gestation	—

Countries

India

Contacts

Public ContactSree Supriya M

A4 Hospital and Fertility centre

drsreesupriya@a4fertility.com9750878983

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026